Vanguard Group’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $25M | Buy |
|
|||||
|
2022
Q4 | $33.5M | Buy |
|
|||||
|
2022
Q3 | $27.9M | Buy |
|
|||||
|
2022
Q2 | $26.1M | Buy |
|
|||||
|
2022
Q1 | $16.8M | Buy |
|
|||||
|
2021
Q4 | $8.36M | Sell |
|
|||||
|
2021
Q3 | $10.8M | Buy |
|
|||||
|
2021
Q2 | $9.16M | Buy |
|
|||||
|
2021
Q1 | $8.86M | Buy |
|
|||||
|
2020
Q4 | $9.54M | Buy |
|
|||||
|
2020
Q3 | $6.1M | Buy |
|
|||||
|
2020
Q2 | $2.49M | Hold |
|
|||||
|
2020
Q1 | $1.98M | Buy |
|
|||||
|
2019
Q4 | $2.4M | Buy |
|
|||||
|
2019
Q3 | $1.11M | Buy |
|
|||||
|
2019
Q2 | $907K | Sell |
|
|||||
|
2019
Q1 | $1.46M | Buy |
|
|||||
|
2018
Q4 | $1.1M | Sell |
|
|||||
|
2018
Q3 | $5.16M | Sell |
|
|||||
|
2018
Q2 | $11.9M | Buy |
|
|||||
|
2018
Q1 | $8.4M | Buy |
|
|||||
|
2017
Q4 | $2.28M | Sell |
|
|||||
|
2017
Q3 | $3.43M | Buy |
|
|||||
|
2017
Q2 | $2.49M | Sell |
|
|||||
|
2017
Q1 | $3.41M | Buy |
|
|||||
|
2016
Q4 | $3.06M | Buy |
|
|||||
|
2016
Q3 | $2.76M | Sell |
|
|||||
|
2016
Q2 | $2.6M | Sell |
|
|||||
|
2016
Q1 | $4.42M | Buy |
|
|||||
|
2015
Q4 | $8.17M | Buy |
|
|||||
|
2015
Q3 | $8.66M | Buy |
|
|||||
|
2015
Q2 | $10.9M | Buy |
|
|||||
|
2015
Q1 | $9.72M | Buy |
|
|||||
|
2014
Q4 | $10.8M | Buy |
|
|||||
|
2014
Q3 | $10.1M | Buy |
|
|||||
|
2014
Q2 | $10.8M | Buy |
|
|||||
|
2014
Q1 | $12.6M | Buy |
|
|||||
|
2013
Q4 | $4.74M | Buy |
|
|||||
|
2013
Q3 | $3.72M | Buy |
|
|||||
|
2013
Q2 | $2.27M | Buy |
|